431 related articles for article (PubMed ID: 19689430)
1. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
Matthiesen K; Nielsen J
Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP.
Handa N; Mizohata E; Kishishita S; Toyama M; Morita S; Uchikubo-Kamo T; Akasaka R; Omori K; Kotera J; Terada T; Shirouzu M; Yokoyama S
J Biol Chem; 2008 Jul; 283(28):19657-64. PubMed ID: 18477562
[TBL] [Abstract][Full Text] [Related]
3. The GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase (PDE5) is a sensor and a sink for cGMP.
Biswas KH; Sopory S; Visweswariah SS
Biochemistry; 2008 Mar; 47(11):3534-43. PubMed ID: 18293931
[TBL] [Abstract][Full Text] [Related]
4. GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides.
Martinez SE; Beavo JA; Hol WG
Mol Interv; 2002 Sep; 2(5):317-23. PubMed ID: 14993386
[TBL] [Abstract][Full Text] [Related]
5. Sodium regulation of GAF domain function.
Cann MJ
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1032-4. PubMed ID: 17956270
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical aspects of tandem GAF domains.
Schultz JE
Handb Exp Pharmacol; 2009; (191):93-109. PubMed ID: 19089327
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization.
Weeks JL; Zoraghi R; Francis SH; Corbin JD
Biochemistry; 2007 Sep; 46(36):10353-64. PubMed ID: 17696499
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
Beltman J; Becker DE; Butt E; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
Mol Pharmacol; 1995 Feb; 47(2):330-9. PubMed ID: 7870041
[TBL] [Abstract][Full Text] [Related]
9. Trypanosome cyclic nucleotide phosphodiesterase 2B binds cAMP through its GAF-A domain.
Laxman S; Rascón A; Beavo JA
J Biol Chem; 2005 Feb; 280(5):3771-9. PubMed ID: 15563461
[TBL] [Abstract][Full Text] [Related]
10. Changes in purine specificity in tandem GAF chimeras from cyanobacterial cyaB1 adenylate cyclase and rat phosphodiesterase 2.
Linder JU; Bruder S; Schultz A; Schultz JE
FEBS J; 2007 Mar; 274(6):1514-23. PubMed ID: 17302738
[TBL] [Abstract][Full Text] [Related]
11. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains.
Yuasa K; Kanoh Y; Okumura K; Omori K
Eur J Biochem; 2001 Jan; 268(1):168-78. PubMed ID: 11121118
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights.
Heikaus CC; Pandit J; Klevit RE
Structure; 2009 Dec; 17(12):1551-1557. PubMed ID: 20004158
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of the PDE6 GAF A domain for binding the inhibitory gamma-subunit and noncatalytic cGMP.
Muradov H; Boyd KK; Artemyev NO
Vision Res; 2004; 44(21):2437-44. PubMed ID: 15358079
[TBL] [Abstract][Full Text] [Related]
17. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.
Kunz S; Oberholzer M; Seebeck T
FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277
[TBL] [Abstract][Full Text] [Related]
18. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
[TBL] [Abstract][Full Text] [Related]
19. Cyclic guanosine 5'-monophosphate binding to regulatory GAF domains of photoreceptor phosphodiesterase.
Cote RH
Methods Mol Biol; 2005; 307():141-54. PubMed ID: 15988061
[TBL] [Abstract][Full Text] [Related]
20. Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5.
Sopory S; Balaji S; Srinivasan N; Visweswariah SS
FEBS Lett; 2003 Mar; 539(1-3):161-6. PubMed ID: 12650945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
